CPA CPA - Vivos Chief Officer

RDGL Stock  USD 0.09  0.01  10.00%   

Insider

CPA CPA is Chief Officer of Vivos Inc
Age 57
Phone509 736 4000
Webhttps://www.radiogel.com

Vivos Management Efficiency

The company has return on total asset (ROA) of (0.6206) % which means that it has lost $0.6206 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.174) %, meaning that it created substantial loss on money invested by shareholders. Vivos' management efficiency ratios could be used to measure how well Vivos manages its routine affairs as well as how well it operates its assets and liabilities.
Vivos Inc currently holds 295.76 K in liabilities with Debt to Equity (D/E) ratio of 0.21, which may suggest the company is not taking enough advantage from borrowing. Vivos Inc has a current ratio of 12.46, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Vivos until it has trouble settling it off, either with new capital or with free cash flow. So, Vivos' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vivos Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vivos to invest in growth at high rates of return. When we think about Vivos' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Erica BellCellink AB
50
Richard GinnTenon Medical
58
Itedale RedwanCellink AB
N/A
Trent NorthcuttAurora Spine
56
Jason CliftonBICO Group AB
N/A
Niclas EmanuelssonBICO Group AB
52
Niclas EmanuelssonCellink AB
52
David MeyerAurora Spine
N/A
Laszlo GaramszegiAurora Spine
52
Artur AiraBICO Group AB
56
Asa HillstenCellink AB
48
Karin DanielssonBICO Group AB
41
Itedale RedwanBICO Group AB
N/A
Jason CliftonCellink AB
N/A
Mikael EngblomBICO Group AB
46
Mikael EngblomCellink AB
46
Artur AiraCellink AB
56
Erica BellBICO Group AB
50
Erik GatenholmBICO Group AB
34
Asa HillstenBICO Group AB
48
Erik GatenholmCellink AB
34
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington. VIVOS INC operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1 people. Vivos Inc [RDGL] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Vivos Inc Leadership Team

Elected by the shareholders, the Vivos' board of directors comprises two types of representatives: Vivos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vivos. The board's role is to monitor Vivos' management team and ensure that shareholders' interests are well served. Vivos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vivos' outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CPA, Chief Officer
Michael Korenko, President CEO, Director
FuMin Su, Chief Officer
PE MS, Chief Mang
Carlton DDS, Independent Sec
Dr BSc, Chief Officer

Vivos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Vivos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Vivos OTC Stock

Vivos financial ratios help investors to determine whether Vivos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vivos with respect to the benefits of owning Vivos security.